XZXiao-Yang Zhang

Xiao-Yang Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiao-Yang Zhang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Chunrui Yang

    Department of Pathology, Second Hospital of Tianjin Medical University, Tianjin, China

    1 shared publication
  • Jiangtao Cui

    Departmentof Oral and Maxillofacial Surgery, Second Hospital of Tianjin Medical University, Tianjin, China

    1 shared publication
  • Justin A. Bishop

    Department of Pathology, UT Southwestern Medical Center, Dallas, USA

    1 shared publication
  • Lu Li

    Department of Gastroenterology, The Second Hospital of Tianjin Medical University, Tianjin, China

    1 shared publication
  • Man Li

    Department of Gastroenterology, The Second Hospital of Tianjin Medical University, Tianjin, China

    1 shared publication
  • Meizhou Liu

    Department of Radiology, Second Hospital of Tianjin Medical University, Tianjin, China

    1 shared publication

Latest Publications

  • Indole-3-carbaldehyde mitigates fibrosis progression in MASH with T2DM via the SIRT1/TGF-β/SMAD signaling pathway

    by Lu Li, Zeyu Wang, Yinglan Ji, Raorao Wang, Xiangjuan Qi, Yana Zhu, Yaping Wang, Xiaoyang Zhang, Man Li, Yong Jiang

  • Palisading Adenocarcinoma: Several New Inherited Cases in Six Patients of a Familial Cohort

    by Xiaoyang Zhang, Justin A. Bishop, Chunrui Yang, Yuyan Yang, Jiangtao Cui, Meizhou Liu

    Introduction The past two decades have seen the introduction of several new variants of established salivary gland tumors, along with occasional, entirely novel entities. Palisading adenocarcinoma was described in 2023 with a handful of subsequent additional case reports. We encountered several seemingly inherited cases of palisading adenocarcinoma in a familial cohort. Methods Within the affected family, all available archival surgical pathology and cytopathology material was retrieved and reviewed. Clinical history was obtained through chart review. Whole-exome sequencing was performed on two cases. Results Six patients were affected by palisading adenocarcinoma. The patients ranged from 33 to 72 years (mean, 52.3 years) and were all women. Each patient had ≥ 2 documented tumors, and the locations of involvement were: parotid gland (n = 7), floor of mouth (n = 4), submandibular gland (n = 3), neck (n = 2), orbit (n = 1), and maxilla (n = 1). Although not every clinically documented case was available for histologic review, all cases that were evaluated demonstrated the features described for palisading adenocarcinoma, including two cell populations of ducts with polygonal neuroendocrine-like cells arranged as trabeculae with palisading, and strong positivity for CD56 but not other neuroendocrine markers. Whole-exome sequencing did not reveal any recurrent alterations. Conclusion We present 18 new cases of palisading adenocarcinoma, including 12 documented pathologically, occurring in women in the same family. This series doubles the published experience of this emerging tumor. While most of the previously published features of palisading adenocarcinoma were confirmed (female predominance, Asian population, sublingual and submandibular location), this series expands what is known about this neoplasm with novel sites (with parotid gland being most common) and apparent inheritability, a very rare characteristic among salivary gland neoplasms. While we were unable to uncover its molecular driver, this potential inheritability is a clue that may allow for future studies to unravel the genetics of palisading adenocarcinoma.


  • Open Access

    An unusual case of aggressive systemic mastocytosis mimicking hepatic cirrhosis

    by Xiao-Yang Zhang, Wei-Hua Zhang

    Hepatic involvement in aggressive systemic mastocytosis (ASM) is relatively common, and the main clinical features of this disease include hepatomegaly, portal hypertension, ascites, and fibrosis. Cirrhosis is a rare ASM symptom. We report an ASM case that initially mimicked cirrhosis based on clinical and radiographic analyses. The portal tract was expanded by mononuclear inflammatory cells, and an increase in collagen amount was observed in routine histological sections of the biopsied liver. A diagnosis of systemic mastocytosis (SM) was made after ancillary tests for mast cells using bone marrow aspirates. Extensive involvement of the liver and gastrointestinal tract was observed. Clinicians and pathologists need to consider ASM as a diagnosis or differential diagnosis in a clinical case of cirrhosis with unknown etiology. The diagnosis can be confirmed or disregarded by immunohistochemical staining and molecular analysis.